Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil.
第一作者:
Andreia Cristina,de Melo
第一单位:
Department of Pathology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
作者:
医学主题词
腺癌(Adenocarcinoma);腺癌, 乳头状(Adenocarcinoma, Papillary);老年人(Aged);老年人, 80以上(Aged, 80 and over);氨基酸取代(Amino Acid Substitution);巴西(Brazil);癌, 腺泡细胞(Carcinoma, Acinar Cell);无病生存(Disease-Free Survival);女(雌)性(Female);基因缺失(Gene Deletion);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);基因重排(Gene Rearrangement);人类(Humans);肺肿瘤(Lung Neoplasms);淋巴转移(Lymphatic Metastasis);男(雄)性(Male);中年人(Middle Aged);突变(Mutation);肿瘤分期(Neoplasm Staging);试验预期值(Predictive Value of Tests);预后(Prognosis);原癌基因蛋白质类(Proto-Oncogene Proteins);原癌基因蛋白质类p21(ras)(Proto-Oncogene Proteins p21(ras));受体蛋白质酪氨酸激酶类(Receptor Protein-Tyrosine Kinases);危险因素(Risk Factors);吸烟(Smoking);存活率分析(Survival Analysis);ras蛋白质类(ras Proteins)
DOI
10.1159/000376552
PMID
25833149
发布时间
2019-02-21
- 浏览15
Oncology
175-86页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



